第一作者机构：[1]Hebei Med Univ, Dept Med Oncol, Hosp 4, Shijiazhuang, Hebei, Peoples R China
推荐引用方式(GB/T 7714)：
Jiang Da,Fu Yuhui,Zhou Xinliang,et al.The prognosis of EGFR complex mutation or co-mutation with tyrosine kinase inhibitor treatment in non-small cell lung cancer[J].JOURNAL OF CLINICAL ONCOLOGY.2022,40(16):doi:10.1200/JCO.2022.40.16_suppl.e21086.
APA：
Jiang, Da,Fu, Yuhui,Zhou, Xinliang,Li, Ying,Cui, Yanzhi...&Deng, Ruoying.(2022).The prognosis of EGFR complex mutation or co-mutation with tyrosine kinase inhibitor treatment in non-small cell lung cancer.JOURNAL OF CLINICAL ONCOLOGY,40,(16)
MLA：
Jiang, Da,et al."The prognosis of EGFR complex mutation or co-mutation with tyrosine kinase inhibitor treatment in non-small cell lung cancer".JOURNAL OF CLINICAL ONCOLOGY 40..16(2022)
医学